(Q40394318)

20 September 2017

1 reference

title

Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment (English)

1 reference

arteriosclerotic heart disease

20 September 2017

1 reference

1 reference

A N Nafziger

1

1 reference

20 September 2017

publication date

1 July 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

48

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

1-8

1 reference

Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages.

20 September 2017

cites work

1 reference

12 December 2020

Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes

1 reference

12 December 2020

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

1 reference

12 December 2020

Plasma lipoprotein levels as predictors of cardiovascular death in women.

1 reference

12 December 2020

Over 80 years and no evidence of coronary heart disease: characteristics of a survivor group

1 reference

12 December 2020

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

12 December 2020

Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study.

1 reference

12 December 2020

Effects of exercise training on glucose control, lipid metabolism, and insulin sensitivity in hypertriglyceridemia and non-insulin dependent diabetes mellitus.

1 reference

12 December 2020

Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah

1 reference

12 December 2020

Familial aggregation of lipids and lipoproteins and early identification of dyslipoproteinemia. The Collaborative Lipid Research Clinics Family Study

1 reference

12 December 2020

Superoxide initiates oxidation of low density lipoprotein by human monocytes

1 reference

12 December 2020

Investigations into the haemorheological significance of postprandial and fasting hypertriglyceridaemia.

1 reference

12 December 2020

Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia

1 reference

12 December 2020

Epidemiology of triglycerides: a view from Framingham

1 reference

12 December 2020

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

12 December 2020

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

12 December 2020

Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity

1 reference

12 December 2020

Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for Atherosclerosis

1 reference

12 December 2020

Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease

1 reference

12 December 2020

NIH Consensus conference. Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease

1 reference

12 December 2020

Metabolism of triglyceride-rich lipoproteins during alimentary lipemia

1 reference

12 December 2020

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

12 December 2020

The Dubbo study of the health of elderly: correlates of coronary heart disease at study entry

1 reference

12 December 2020

Consensus conference: Treatment of hypertriglyceridemia

1 reference

12 December 2020

Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins

1 reference

12 December 2020

Normalisation of the composition of very low density lipoprotein in hypertriglyceridemia by nicotinic acid

1 reference

12 December 2020

Omega-3 fatty acids. Current status in cardiovascular medicine

1 reference

12 December 2020

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

1 reference

12 December 2020

Will a high-carbohydrate, low-fat diet lower plasma lipids and lipoproteins without producing hypertriglyceridemia?

1 reference

12 December 2020

Effect of gemfibrozil and lovastatin on postprandial lipoprotein clearance in the hypoalphalipoproteinemia and hypertriglyceridemia syndrome.

1 reference

12 December 2020

The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society

1 reference

12 December 2020

Plasma triglyceride level and mortality from coronary heart disease

1 reference

12 December 2020

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia

1 reference

12 December 2020

Low-dose, time-release nicotinic acid: effects in selected patients with low concentrations of high-density lipoprotein cholesterol

1 reference

12 December 2020

Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.

1 reference

12 December 2020

Pathogenesis of alcohol-induced hypertriglyceridemia

1 reference

12 December 2020

The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study

1 reference

12 December 2020

Triglycerides, a major coronary risk factor in elderly men. A study of men born in 1913

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients

1 reference

12 December 2020

Delayed clearance of postprandial chylomicrons and their remnants in the hypoalphalipoproteinemia and mild hypertriglyceridemia syndrome

1 reference

12 December 2020

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond

1 reference

12 December 2020

Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia

1 reference

12 December 2020

Triglyceride levels and the risk of coronary artery disease: a view from Australia

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise

1 reference

12 December 2020

Patients with combined hypercholesterolemia-hypertriglyceridemia show an increased monocyte-endothelial cell adhesion in vitro: triglyceride level as a major determinant

1 reference

12 December 2020

Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications

1 reference

12 December 2020

10.2165/00003495-199448010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1029884161

0 references

1 reference